ArticleCureus2026
Severe Peripartum Cardiomyopathy With Complete Functional Recovery: The Role of Multimodality Imaging and Optimized Medical Therapy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peripartum cardiomyopathy (PPCM) is a life-threatening, idiopathic form of heart failure with a highly variable recovery trajectory. While normalization of the left ventricular ejection fraction (LVEF) is frequently achieved, identifying residual myocardial injury and subclinical dysfunction remains a significant diagnostic challenge. A 25-year-old woman presented with acute heart failure seven weeks postpartum, following a pregnancy complicated by preeclampsia. Initial multimodality imaging revealed severe biventricular dysfunction (LVEF 14%, right ventricular ejection fraction 17%), intracavitary apical thrombi at the left ventricular apex, and a peak NT-proBNP of 12,241 pg/mL. Comprehensive management included therapeutic anticoagulation (initially with bemiparin), early guideline-directed medical therapy, and a prolonged 12-week course of bromocriptine. At the 18-month follow-up, the patient achieved complete clinical recovery (New York Heart Association (NYHA) class I) with normalization of LVEF. However, advanced imaging identified persistent subclinical impairment, evidenced by an abnormal global longitudinal strain (averaging -15.0%) and focal myocardial fibrosis (3% of total mass) on cardiac magnetic resonance. This case illustrates that clinical and conventional echocardiographic recovery in PPCM may mask persistent subclinical myocardial dysfunction. It emphasizes the necessity of multimodality imaging, specifically speckle-tracking strain analysis and tissue characterization, to accurately define the true spectrum of myocardial recovery and guide long-term risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.